ArticleScientific reports2017

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.

Taisuke Imamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.